Kroger Co vs Novo Nordisk A/S — how do they compare? Kroger Co trades at $57.74 (market cap $35.75B), while Novo Nordisk A/S trades at $49.35 (market cap $220.53B). The key difference: Novo Nordisk A/S is far larger — about 6.2× Kroger Co's market cap, and Novo Nordisk A/S pays the higher dividend (3.63%). Which is the better fit depends on your goals.
| KR | NVO | |
|---|---|---|
Market Cap | $35.75B | $220.53B |
Sector | Consumer Staples | Health |
52-Week High | $75.60 | $71.70 |
52-Week Low | $55.53 | $35.29 |
Enterprise Value | $55.85B | $239.49B |
Dividend Yield | 2.47% | 3.63% |
Trailing returns across standard periods
Latest headlines on both assets
Kroger is the leading American grocer, with 2,726 supermarkets operating under several banners throughout the country as of the end of fiscal 2021. Around 83% of stores have pharmacies, while nearly 60% also sell fuel. The company also operates roughly 120 fine jewelry stores. Kroger features a leading private-label offering and manufactures around 30% of its own-brand units (and more than 40% of its grocery own-label assortment) itself, in 33 food production plants nationwide. Kroger is a top-two grocer in most of its major markets (as of early 2021, according to company data). Virtually all of Kroger's sales come from the United States.
Read more on KR →With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →